Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
, 147 (5), 622-6

A Clinical Pathway for Bronchiolitis Is Effective in Reducing Readmission Rates

Controlled Clinical Trial

A Clinical Pathway for Bronchiolitis Is Effective in Reducing Readmission Rates

Joyce Cheney et al. J Pediatr.


Objective: To examine the use of a clinical pathway in the management of infants hospitalized with acute viral bronchiolitis.

Study design: A clinical pathway with specific management and discharge criteria for the care of infants with bronchiolitis was developed from pathways used in tertiary care pediatric institutions in Australia. Two hundred and twenty-nine infants admitted to hospital with acute viral bronchiolitis and prospectively managed using a pathway protocol were compared with a retrospective analysis of 207 infants managed without a pathway in 3 regional and 1 tertiary care hospital.

Results: Readmission to hospital was significantly lower in the pathway group (P = .001), as was administration of supplemental fluids (P = .001) and use of steroids (P = .005). There were no differences between groups in demographic factors or clinical severity. The pathway had no overall effect on length of stay or time in oxygen.

Conclusions: A clinical pathway specifying local practice guidelines and discharge criteria can reduce the risk of readmission to hospital, the use of inappropriate therapies, and help with discharge planning.

Comment in

Similar articles

See all similar articles

Cited by 16 PubMed Central articles

See all "Cited by" articles

Publication types

LinkOut - more resources